A study reveals a 300-fold increase in weight-loss drug prescriptions for U.S. children under 12, highlighting access disparities.

Weight-loss formulations are only approved for kids 12 years and older

One in five children suffers from obesity, a chronic condition leaving them at greater risk of cancer and heart disease